Re-Addressing Dementia by Network Medicine and Mechanism-Based Molecular Endotypes.
Mayra Pacheco Pachado, Ana I Casas, Mahmoud H Elbatreek...
https://pubmed.ncbi.nlm.nih.gov/37742653/Actively Recruiting
Led by Michael J. Fox Foundation for Parkinson's Research · Updated on 2026-07-27
4500
Participants Needed
50
Research Sites
N/A
Total Duration
Researchers are conducting the Parkinsons Progression Marker Initiative PPMI, a large, multi-center, observational study to track the progression of Parkinsons disease PD over time. This study includes participants with diagnosed PD, those at risk prodromal PD, and healthy controls. It aims to identify markers related to PD progression by collecting clinical, digital, imaging, biological, and genetic data, which could help in developing therapies to slow PD disability progression. PPMI Clinical plans to enroll up to 4,500 participants who will be followed for 5 to 8 years. Participants may also be invited to join additional related programs such as PPMI Remote, PPMI Digital App, or PPMI Online, depending on their recruitment method and cohort classification. The study collects a wide range of data including clinical assessments, digital outcomes, imaging scans, biological samples, and genetic testing. Participants may undergo repeated evaluations, including imaging tests like SPECT, and provide information through questionnaires and digital tools. Throughout the study, participants will attend visits at regular intervals to undergo assessments that help researchers measure disease progression and compare changes over time. Data collected includes clinical signs, imaging results, biological markers, and genetic information. The study also monitors the probability of disease development in at-risk individuals. The overall duration of participation can extend up to 13 years, ensuring comprehensive long-term data collection and safety monitoring.
CONDITIONS
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
C
Cari Rainville, BS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Michael J. Fox Foundation for Parkinson's Research
Lead Sponsor
Institute for Neurodegenerative Disorders
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 5 to 8 years
Participants are followed over time with regular assessments including clinical exams, imaging, biological sample collection, and questionnaires to track Parkinson's disease progression and related markers.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Mayra Pacheco Pachado, Ana I Casas, Mahmoud H Elbatreek...
https://pubmed.ncbi.nlm.nih.gov/37742653/Michael J. Fox Foundation for Parkinson's Research
Lead Sponsor
Institute for Neurodegenerative Disorders
Collaborating Sponsor